OS Therapies Incorporated (OSTX)

US · Healthcare · Biotechnology

$1.83+4.57%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-8.6M

EPS

$-0.20

EPS estimate

$-0.25

EPS came in at -0.20 against a street estimate of -0.25 — a beat of 20.0%.

Market cap

$81.9M

Forward P/E

1.7

P/B

13.65

Book value

$-0.26

EPS (TTM)

$-1.07

52-week high

$2.25

52-week low

$1.15

50-day MA

$1.62

200-day MA

$1.59

Beta

-0.68

Analysts rate OS Therapies Incorporated a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $8.50.

Insiders

21.21%

Institutions

6.25%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OS Therapies Incorporated — free to start.

Data updated 2026-09-18.